ArticleThe American journal of case reports2026
From Sight to Stridor: Recurrent Angioedema in Systemic Lupus Erythematosus Associated With Complement Activation.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Angioedema is a rare manifestation of systemic lupus erythematosus (SLE) that can lead to life-threatening complications, including airway compromise. Acquired angioedema is classically associated with C1 esterase inhibitor (C1-INH) deficiency caused either by increased consumption of C1-INH or the development of autoantibodies against C1-INH. However, emerging reports describe patients with active SLE who develop recurrent angioedema despite preserved C1-INH levels and function, suggesting a possible complement-mediated or bradykinin-associated inflammatory phenotype that remains incompletely characterized. CASE REPORT We report the case of a woman in her early 20s with SLE and lupus nephritis who presented with a urinary tract infection and unilateral periorbital edema. Initial laboratory evaluation revealed anemia, thrombocytopenia, and acute-on-chronic kidney injury. She was treated with antibiotics for presumed urinary tract infection and preseptal cellulitis. During hospitalization, she developed laryngeal edema requiring prompt treatment with intravenous dexamethasone, with rapid clinical improvement. Further evaluation demonstrated low C4 and C1q complement levels, elevated C1q complement binding levels, elevated anti-C1q antibodies, and preserved C1-INH antigen and functional levels, raising suspicion for complement-mediated angioedema occurring in the setting of active SLE. Over the ensuing 6 months, she experienced recurrent episodes of angioedema with progressive renal dysfunction and concern for evolving macrophage activation syndrome or severe hyperinflammatory immune activation. CONCLUSIONS This case highlights a rare presentation of recurrent angioedema associated with active SLE and complement activation despite preserved C1-INH levels and function. The case underscores the importance of early recognition of airway involvement in patients with lupus and illustrates the diagnostic challenges surrounding complement-mediated angioedema phenotypes in autoimmune disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.